» Articles » PMID: 24485874

Sweat Conductivity: an Accurate Diagnostic Test for Cystic Fibrosis?

Overview
Journal J Cyst Fibros
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2014 Feb 4
PMID 24485874
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sweat chloride test is the gold standard test for cystic fibrosis (CF) diagnosis. Sweat conductivity is widely used although still considered a screening test.

Methods: This was a prospective, cross-sectional, diagnostic research conducted at the laboratory of the Instituto da Criança of the Hospital das Clínicas, São Paulo, Brazil. Sweat chloride (quantitative pilocarpine iontophoresis) and sweat conductivity tests were simultaneously performed in patients referred for a sweat test between March 2007 and October 2008. Conductivity and chloride cut-off values used to rule out or diagnose CF were <75 and ≥90 mmol/L and <60 and ≥60 mmol/L, respectively. The ROC curve method was used to calculate the sensitivity, specificity, positive (PPV) and negative predictive value (NPV), as well as the respective 95% confidence intervals and to calculate the area under the curve for both tests. The kappa coefficient was used to evaluate agreement between the tests.

Results: Both tests were performed in 738 children, and CF was ruled out in 714 subjects; the median sweat chloride and conductivity values were 11 and 25 mmol/L in these populations, respectively. Twenty-four patients who had received a diagnosis of CF presented median sweat chloride and conductivity values of 87 and 103 mmol/L, respectively. Conductivity values above 90 mmol/L had 83.3% sensitivity, 99.7% specificity, 90.9% PPV and 99.4% NPV to diagnose CF. The best conductivity cut-off value to exclude CF was <75 mmol/L. Good agreement was observed between the tests (kappa: 0.934).

Conclusions: The sweat conductivity test yielded a high degree of diagnostic accuracy and it showed good agreement with sweat chloride. We suggest that it should play a role as a diagnostic test for CF in the near future.

Citing Articles

Diagnosing cystic fibrosis in low- and middle-income countries: challenges and strategies.

Fuhrer M, Zampoli M, Abriel H Orphanet J Rare Dis. 2024; 19(1):482.

PMID: 39707455 PMC: 11662431. DOI: 10.1186/s13023-024-03506-1.


Diagnosing Cystic Fibrosis in the 21st Century-A Complex and Challenging Task.

Anton-Paduraru D, Azoicai A, Trofin F, Mindru D, Murgu A, Bocec A Diagnostics (Basel). 2024; 14(7).

PMID: 38611676 PMC: 11012009. DOI: 10.3390/diagnostics14070763.


Full-Cut Manufacture of Skin-Interfaced Microfluidic Patch with Copper Electrode for In Situ Admittance Sensing of Sweat Rate.

Wei L, He Y, Lv Z, Guo D, Cheng L, Wu H Biosensors (Basel). 2023; 13(1).

PMID: 36671902 PMC: 9855928. DOI: 10.3390/bios13010067.


Genetic spectrum of Chinese children with cystic fibrosis: comprehensive data analysis from the main referral centre in China.

Shen Y, Tang X, Chen Q, Xu H, Liu H, Liu J J Med Genet. 2022; .

PMID: 35858753 PMC: 9985745. DOI: 10.1136/jmg-2022-108501.


Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome.

Zampoli M, Verstraete J, Frauendorf M, Kassanjee R, Workman L, Morrow B ERJ Open Res. 2021; 7(3).

PMID: 34350279 PMC: 8326682. DOI: 10.1183/23120541.00856-2020.